ATZUMI
Active substance: dihydroergotamine
POWDER · DIHYDROERGOTAMINE MESYLATE 5.2 mg/1
United StatesActive
Marketing holder: Satsuma Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DIHYDROERGOTAMINE MESYLATE · 5.2 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5764-793c-8ac3-7133c43f2c60,01a1208c-c62a-77fa-838c-625e35e7a866,01a1208c-d49b-7697-aaa4-266c4fe3d7c4,01a1208d-746a-7a36-8cf4-26946aca7446,01a1208d-98bf-73c3-a655-e864645549f8;count=15 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 76978-101
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- NASAL
Sources
- product · openFDA NDC · 76978-101 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 76978-101 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 76978-101 · Verified 2026-10-09 · open in source